CIK 0001819790
- Large accelerated filer
Tarsus Pharmaceuticals, Inc.
Sign in to watch- Ticker
- TARS
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 814717861
- Phone
- +1 949-409-9820
- Business address
- 15440 LAGUNA CANYON ROAD, IRVINE, CA, 92618
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $5,995,859
- in 7 filings, $6.0M under 10b5-1 plans
Net −$5,995,859. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-09-20 | Azamian Bobak R. President/CEO and Board Chair | Sale 10b5-1 | −8,000 | $17.21 | $138K | 894,106 |
| 2023-09-15 | Morrison Scott W Director | Exercise or conversion | +1,333 | 1,333 | ||
| 2023-09-15 | Morrison Scott W Director | Exercise or conversion · Restricted Stock Units | −1,333 | 2,667 | ||
| 2023-08-23 | Azamian Bobak R. President/CEO and Board Chair | Sale 10b5-1 | −8,000 | $17.23 | $138K | 902,106 |
| 2023-08-15 | Lin Elizabeth Yeu Director | Purchase | +9,506 | $16.80 | $160K | 15,866 |
| 2023-07-19 | Azamian Bobak R. President/CEO and Board Chair | Sale 10b5-1 | −4,174 | $19.28 | $80K | 1,009,832 |
| 2023-07-19 | Azamian Bobak R. President/CEO and Board Chair | Sale 10b5-1 | −99,726 | $20.04 | $2.0M | 910,106 |
| 2023-07-19 | Mottiwala Aziz Chief Commercial Officer | Sale 10b5-1 | −2,400 | $20.05 | $48K | 45,806 |
| 2023-07-12 | Azamian Bobak R. President/CEO and Board Chair | Sale 10b5-1 | −9,000 | $17.35 | $156K | 1,014,006 |
| 2023-06-22 | Crane Rosemary A Director | Grant or award · Stock Option (right to buy) | +5,000 | 5,000 | ||
| 2023-06-22 | Crane Rosemary A Director | Grant or award · Restricted Stock Units | +3,350 | 3,350 | ||
| 2023-06-22 | CHAUDHURI BHASKAR Director | Grant or award · Stock Option (right to buy) | +5,000 | 5,000 | ||
| 2023-06-22 | CHAUDHURI BHASKAR Director | Grant or award · Restricted Stock Units | +3,350 | 3,350 | ||
| 2023-06-22 | Goldberg Andrew D. Director | Grant or award · Stock Option (right to buy) | +5,000 | 5,000 | ||
| 2023-06-22 | Goldberg Andrew D. Director | Grant or award · Restricted Stock Units | +3,350 | 3,350 | ||
| 2023-06-22 | Lin Elizabeth Yeu Director | Grant or award · Stock Option (right to buy) | +5,000 | 5,000 | ||
| 2023-06-22 | Lin Elizabeth Yeu Director | Grant or award · Restricted Stock Units | +3,350 | 3,350 | ||
| 2023-06-22 | LINK WILLIAM J PHD Director | Grant or award · Stock Option (right to buy) | +5,000 | 5,000 | ||
| 2023-06-22 | LINK WILLIAM J PHD Director | Grant or award · Restricted Stock Units | +3,350 | 3,350 | ||
| 2023-06-22 | Morrison Scott W Director | Grant or award · Stock Option (right to buy) | +5,000 | 5,000 |
Page 18 of 24 · 469 trades